Two studies (one of them is included in our meta-analysis) concluded that RASSF1A methylation in NB patients was statistically significantly more prevalent in the age group > 1 year, compared to the age group < 1 year [21, 38]. This evidence concerns the gene RASSF1 and neuroblastoma.